Girish Mahajan (Editor)

Institut Mérieux

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Founded
  
1897


Subsidiaries
  
Mérieux NutriSciences, BioMérieux, Transgene SA, THERA Conseil, Imaccess, ABL, Inc., Omnimedic, Inc.

Martina gliber director of external relations institut m rieux


Institut Mérieux is a French holding company owned by the Mérieux family from Lyon.

Contents

B roll alain m rieux institut m rieux meningitis outbreak in brazil 1974 in french


History

It was created by Marcel Mérieux in 1897 under the name Institut Biologique Mérieux (Mérieux Biological Institute). The vaccine development branch of the institute was separated early on and is now part of Sanofi Pasteur.,, The current name was changed in 2009 from Mérieux Alliance. The holding is owned through the Mérieux Alliance company at 68% by Alain and Alexandre Mérieux and at 32% by the Christophe and Rodolphe Mérieux foundation (different from the Mérieux foundation).

Holding

Through creations and acquisitions, the holding is managing the following companies:,,

  • BioMérieux, created by Alain Mérieux in 1963, owned at 59%
  • Mérieux NutriSciences, renamed from the acquired Chicago-based company Silliker, and encompassing the Biofortis and Bioagri companies, owned at 70% by the holding
  • Transgene "designs and develops therapeutic vaccines and immunotherapy products to treat cancers and infectious diseases" and is owned at 55% by the holding
  • Advanced BioScience Laboratories, Inc, an unlisted company dedicated to research and development of infectious diseases, AIDS in particular; owned entirely by the holding
  • Mérieux Développement
  • IMAccess a not for profit company dedicated to the development, production and supply of rapid diagnostic tests to developing countries, owned entirely by the holding

    • References

    Institut Mérieux Wikipedia
    (Text) CC BY-SA